Share Name Share Symbol Market Type Share ISIN Share Description
Phorm Corp LSE:PHRM London Ordinary Share SG9999009278 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.00p 0.00p 0.00p - - - 0 05:30:43
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 0.2 -26.0 -5.1 - 9.82

Phorm Corporation Limited Funding Update and Statement re Suspension

25/02/2016 8:02am

UK Regulatory (RNS & others)


Phorm Corp (LSE:PHRM)
Historical Stock Chart

3 Years : From Oct 2015 to Oct 2018

Click Here for more Phorm Corp Charts.

TIDMPHRM

RNS Number : 1193Q

Phorm Corporation Limited

25 February 2016

25 February 2016

Phorm Corporation Limited

("Phorm" or the "Company")

Funding Update and Statement re Suspension

Phorm (AIM: PHRM), a leading advertising-technology company and first party data platform provider, announces a funding update.

As announced on 1 February 2016, the Company has entered into an unsecured short term loan agreement with Meditor European Master Fund Limited ("Meditor") for the provision of a loan facility of up to US$2.75 million to be drawn down in three tranches, dependent on certain conditions being satisfied (the "Loan"). As announced on 4 February 2016, the Company has drawn down on Tranche 1 and 2 of the Loan and, in order to draw down the final US$2.25 million third tranche under the Loan ("Tranche 3"), the Company was required to secure further equity funding of at least GBP2.5 million by 24 February 2016. The Company today announces that it has been unable to secure the requisite equity funding by the Tranche 3 deadline and accordingly the ability to draw down under Tranche 3 has lapsed.

The Company is in advanced discussions with certain of its shareholders and other parties regarding possible alternative financing and a further announcement(s) will be made as soon as possible. There can be no guarantee that such discussions will result in any funds being raised. Pending conclusion of those discussions the Company has requested suspension of its shares from trading on AIM.

-Ends-

For further information please contact:

Phorm Corporation Limited

   Timothy Smith (Chief Executive Officer)                                      +44 (0) 20 3397 6001 
   Mirabaud Securities LLP (Broker)                                           +44 (0) 20 7878 3360 

Peter Krens

   Strand Hanson Limited (Nominated Adviser)                          +44 (0) 20 7409 3494 

James Harris Matthew Chandler James Dance

About Phorm:

Phorm is a leading advertising-technology and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit: www.phorm.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEAPASAEFKEEF

(END) Dow Jones Newswires

February 25, 2016 03:02 ET (08:02 GMT)

1 Year Phorm Corp Chart

1 Year Phorm Corp Chart

1 Month Phorm Corp Chart

1 Month Phorm Corp Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20181021 18:44:42